Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac Sodium Gel in Knee Osteoarthritis
NCT00171626Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2004
- Primary completion
- Jun 2005
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Voltaren gel in osteoarthritis (OA) (2 arms), sponsored by Novartis. Primary endpoints: Western Ontario and McMaster Universities Osteoarthritis Index pain at 12 weeks, Western Ontario and McMaster Universities Osteoarthritis Index physical function at 12 weeks and 1 more. Started Aug 2004; status: completed.
02
Drugs
Voltaren gel
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00171626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00171626.